,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2015-02-16 22:26:00,I t takes some doing for a small fry to make a dent in a market ruled by industry big shots.,0.3805930018424988,0.08453438431024551,0.5348725914955139,neutral,0.29605862498283386
1,2015-02-16 22:26:00,"But that's what software service providerVeeva Systems ( VEEV ) has done since making its market debut in October 2013, as it's taken share from larger rivals that were using older technology.",0.8555208444595337,0.01577780768275261,0.12870129942893982,positive,0.8397430181503296
2,2015-02-16 22:26:00,"Veeva, founded in 2007, specializes in providing cloud-based software to the life sciences industry.",0.055949971079826355,0.004444464575499296,0.9396055936813354,neutral,0.05150550603866577
3,2015-02-16 22:26:00,"Pharmaceutical firms and biotechs use its customer relationship management, or CRM, software to market and sell to doctors and other health care providers more efficiently and effectively, and in compliance with regulations.",0.6503573656082153,0.01009520422667265,0.33954739570617676,positive,0.6402621865272522
4,2015-02-16 22:26:00,"Another product, Veeva Vault, provides cloud-based content management for processes such as clinical trials, quality management, manufacturing, sales and marketing.",0.03870900347828865,0.005364793818444014,0.9559261798858643,neutral,0.03334420919418335
5,2015-02-16 22:26:00,"A third cloud-based software offering, Veeva Network, is used for data management.",0.04460350424051285,0.0047771139070391655,0.9506193995475769,neutral,0.03982638940215111
6,2015-02-16 22:26:00,"Veeva's core CRM offering and complementary products, such as CRM Approved Email, useSalesforce.com 's ( CRM ) Salesforce platform.",0.033656079322099686,0.005296089220792055,0.9610478281974792,neutral,0.028359990566968918
7,2015-02-16 22:26:00,Veeva is Salesforce.com's preferred and recommended Salesforce platform application provider of sales automation solutions for drugmakers in the pharma and biotech industry.,0.42508602142333984,0.009066255763173103,0.5658477544784546,neutral,0.4160197675228119
8,2015-02-16 22:26:00,"Veeva is the ""primary"" company offering cloud-based software-as-a-service, or SaaS, in the life science CRM market, says UBS analyst Steven Valiquette.",0.16909146308898926,0.005493625998497009,0.8254148960113525,neutral,0.16359783709049225
9,2015-02-16 22:26:00,"Veeva's SaaS capabilities have helped it successfully compete with its main rivals in the CRM life science space, which include computer software giantOracle ( ORCL ) and Cegedim, a global technology and services company focused on health care.",0.946956992149353,0.017428698018193245,0.03561427816748619,positive,0.9295282959938049
10,2015-02-16 22:26:00,"""Veeva has been taking a lot of share in the life science CRM market,"" Valiquette told IBD.",0.7121501564979553,0.011755302548408508,0.27609455585479736,positive,0.700394868850708
11,2015-02-16 22:26:00,"""Competitors like Oracle and Cegedim are offering more traditional technology within this marketplace.""",0.6446388959884644,0.012090472504496574,0.3432706296443939,positive,0.632548451423645
12,2015-02-16 22:26:00,He estimates that Veeva has a roughly 45% share of the life science CRM market.,0.06827108561992645,0.0055692847818136215,0.926159679889679,neutral,0.06270179897546768
13,2015-02-16 22:26:00,"Veeva, an IBD 50 stock, gets about 85% of its revenue from its CRM offerings.",0.02444859966635704,0.005911180749535561,0.9696402549743652,neutral,0.01853741891682148
14,2015-02-16 22:26:00,"Oracle and Cegedim are losing share to Veeva, Valiquette adds, as pharmaceutical and biotech companies go through a ""replacement cycle"" and upgrade their technology to newer offerings.",0.02050715498626232,0.9616381525993347,0.017854686826467514,negative,-0.9411309957504272
15,2015-02-16 22:26:00,"He says Veeva is the ""go-to company"" in the life science CRM space for these upgrades.",0.7705112099647522,0.012621212750673294,0.216867595911026,positive,0.757889986038208
16,2015-02-16 22:26:00,Why go with Veeva's technology?,0.05136941745877266,0.03245849907398224,0.9161720871925354,neutral,0.01891091838479042
17,2015-02-16 22:26:00,"""Life sciences organizations generally use on-premises systems that were highly customized and specialized in order to work properly and meet the strict regulatory requirements,"" Valiquette noted in his Feb. 5 initiation report on Veeva, which he rates a buy.",0.2528603971004486,0.007984673604369164,0.7391549348831177,neutral,0.2448757290840149
18,2015-02-16 22:26:00,"And ""Veeva's industry-specific software brings the cloud functionality in a form tailored specifically for the life sciences organizations.""",0.42497310042381287,0.008843652904033661,0.56618332862854,neutral,0.4161294400691986
19,2015-02-16 22:26:00,"When salespeople call on a doctor or other health care provider, Veeva's cloud-based software enables them to have the data they need ""at their fingertips on a tablet and updated in real time, making them more efficient and intelligent,"" says Davis.",0.5063942670822144,0.010923763737082481,0.4826819598674774,positive,0.49547049403190613
20,2015-02-16 22:26:00,"Veeva has been enjoying a nice run, driven by continued growth in its CRM business and increasing momentum from Veeva Vault for content management.",0.955930233001709,0.016765909269452095,0.02730393595993519,positive,0.9391643404960632
21,2015-02-16 22:26:00,Veeva has logged at least double-digit sales and earnings growth in all but two quarters since its IPO .,0.9221705198287964,0.013846613466739655,0.06398286670446396,positive,0.9083238840103149
22,2015-02-16 22:26:00,"In the third quarter, earnings rose 50% to 9 cents per share.",0.9544392824172974,0.018474362790584564,0.027086341753602028,positive,0.9359649419784546
23,2015-02-16 22:26:00,Sales popped 52% to $83.8 million.,0.9015236496925354,0.07255372405052185,0.02592259831726551,positive,0.8289699554443359
24,2015-02-16 22:26:00,"If analysts are on target, Veeva should see double-digit sales and earnings growth when it reports fiscal 2015 fourth-quarter results on March 3 after the stock market close.",0.9323543310165405,0.015932632610201836,0.05171296000480652,positive,0.9164217114448547
25,2015-02-16 22:26:00,"Analysts polled by Thomson Reuters see EPS growing 29% year over year to 9 cents, a slower rate than in the prior quarter.",0.08729256689548492,0.8966789245605469,0.01602853648364544,negative,-0.8093863725662231
26,2015-02-16 22:26:00,"Among the causes is increased spending on R&D and sales and marketing, according to Davis.",0.5289902091026306,0.12169118225574493,0.34931862354278564,positive,0.4072990417480469
27,2015-02-16 22:26:00,"""Also, so far at least, Veeva has tended to exceed consensus forecasts,"" he said.",0.8002423644065857,0.11650463193655014,0.08325289934873581,positive,0.6837377548217773
28,2015-02-16 22:26:00,"""Obviously, no guarantees that they will do that again, but they have done well so far.""",0.9177771806716919,0.028497060760855675,0.05372583493590355,positive,0.8892801403999329
29,2015-02-16 22:26:00,But the growth has helped fuel a nice run for Veeva stock .,0.920978844165802,0.020170141011476517,0.058851029723882675,positive,0.9008086919784546
30,2015-02-16 22:26:00,So far this year it's up 13%.,0.9339691996574402,0.017542878165841103,0.04848799481987953,positive,0.9164263010025024
31,2015-02-16 22:26:00,"""More than anything, it's taking a lot of share in the life science CRM market,"" said Valiquette.",0.08077657967805862,0.8208557367324829,0.09836769104003906,negative,-0.7400791645050049
32,2015-02-16 22:26:00,"Another plus, he adds, is the fact that Veeva has been showing ""very strong"" top-line and earnings growth.",0.9334576725959778,0.015198329463601112,0.05134406313300133,positive,0.91825932264328
33,2015-02-16 22:26:00,"Investors like that Veeva makes a profit on a free cash flow basis and that it has operating margins in the mid- to-high 20s, adds Davis.",0.830355167388916,0.01884806714951992,0.15079687535762787,positive,0.8115071058273315
34,2015-02-16 22:26:00,"Valiquette says that he expects to hear a ""continuation of market share gains"" in Veeva's core life science CRM market in its fourth-quarter report.",0.955028772354126,0.018873639404773712,0.02609758824110031,positive,0.9361551403999329
35,2015-02-16 22:26:00,He sees Veeva growing its share in that market to 70%-75% between now and 2020.,0.9446194767951965,0.01508874911814928,0.04029182717204094,positive,0.9295307397842407
36,2015-02-16 22:26:00,A merger deal is in the offing for one of Veeva's rivals in the life science CRM market.,0.6106641292572021,0.0818721279501915,0.307463675737381,positive,0.5287920236587524
37,2015-02-16 22:26:00,IMS Health ( IMS ) is acquiring Cegedim's information solutions and customer relationship management businesses.,0.18451863527297974,0.006330627016723156,0.809150755405426,neutral,0.1781880110502243
38,2015-02-16 22:26:00,The deal is expected to close early this year.,0.0774855688214302,0.006198709364980459,0.9163156747817993,neutral,0.07128685712814331
39,2015-02-16 22:26:00,"""The impact (of the deal) should be minimal, because Cegedim was losing share and IMS management has stated publicly that CRM is not the focal point of the merger,"" said Valiquette.",0.022776814177632332,0.8749557137489319,0.10226744413375854,negative,-0.8521788716316223
40,2015-02-16 22:26:00,"Veeva has more than 200 customers, including Bayer,Eli Lilly ( LLY ) andNovartis (NVS).",0.09261967986822128,0.004891779273748398,0.9024884700775146,neutral,0.08772790431976318
41,2015-02-16 22:26:00,They see a 21% gain in fiscal 2016 and a 24% increase in 2017.,0.9396333694458008,0.022393103688955307,0.037973564118146896,positive,0.9172402620315552
42,2015-02-16 22:26:00,"Veeva Vault is becoming a ""greater portion of the company's growth trajectory,"" says Valiquette.",0.35162147879600525,0.007834118790924549,0.6405444145202637,neutral,0.34378737211227417
43,2015-02-16 22:26:00,"On the Nov. 25 third-quarter conference call, CEO Peter Gassner said that Veeva has more than 100 Vault customers.",0.19447627663612366,0.009226799011230469,0.7962969541549683,neutral,0.1852494776248932
44,2015-02-16 22:26:00,"In the last 12 months, he added, the company had seen a threefold increase in the total number of Vaults used by Veeva customers.",0.9443010687828064,0.016016973182559013,0.03968201205134392,positive,0.9282841086387634
45,2015-02-16 22:26:00,"In the third quarter alone, Veeva signed three Vault deals with annual contract values in the seven figures, he said.",0.5891233682632446,0.022096823900938034,0.38877975940704346,positive,0.5670265555381775
46,2015-02-16 22:26:00,"""We are seeing great momentum in Veeva Vault,"" Gassner said.",0.9404870271682739,0.014972402714192867,0.04454061761498451,positive,0.9255146384239197
47,2015-02-16 22:26:00,Why is there so much customer interest in Vault?,0.04316423833370209,0.02461041323840618,0.9322252869606018,neutral,0.018553825095295906
48,2015-02-16 22:26:00,"""Today, the industry is stuck on a variety of client service systems that are 10 years to 15 years old,"" said Gassner.",0.05039573833346367,0.01012212410569191,0.9394821524620056,neutral,0.04027361422777176
49,2015-02-16 22:26:00,"""These systems are slow.",0.06961090862751007,0.3455445170402527,0.5848445892333984,neutral,-0.2759336233139038
50,2015-02-16 22:26:00,It can take minutes to find and retrieve a document (and) usability is poor.,0.0282028429210186,0.9141325950622559,0.05766456946730614,negative,-0.8859297633171082
51,2015-02-16 22:26:00,"They're highly customized.""",0.17775961756706238,0.007519871927797794,0.8147205710411072,neutral,0.17023974657058716
52,2015-02-16 22:26:00,"The industry, he adds, wants cloud solutions to ""streamline IT.""",0.4054844081401825,0.008695892058312893,0.585819661617279,neutral,0.39678850769996643
53,2015-02-16 22:26:00,"""With Vault, they get a suite of cloud applications they can typically implement in just a few months because the applications are functionally complete,"" he said.",0.43730732798576355,0.008966771885752678,0.5537259578704834,neutral,0.4283405542373657
54,2015-02-16 22:26:00,Veeva is part of IBD's Computer Software-Medical industry group.,0.03516577184200287,0.004927395842969418,0.9599067568778992,neutral,0.030238375067710876
55,2015-02-16 22:26:00,"It is the second highest-rated company in the group, with a Composite Rating of 93 out of a possible 99.",0.6177751421928406,0.01426849327981472,0.36795637011528015,positive,0.6035066246986389
56,2015-02-16 22:26:00,Cerner (CERN) ranks No.,0.3251034915447235,0.04227782040834427,0.6326186656951904,neutral,0.28282567858695984
57,2015-02-16 22:26:00,"1, with a Composite Rating of 97.",0.08134085685014725,0.010736009106040001,0.90792316198349,neutral,0.0706048458814621
58,2015-02-16 22:26:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
